CD46 and Epstein-Barr virus infection: In the first stage of EBV infection, the human proteins CLOCK, NAT1, SNHG5, CD46, and RNF41 are inhibited by epigenetic modifications, EBV proteins, miRNAs, or the low activity of TFs, and the human body is unable to defeat EBV.